BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2230926
,
SLC12A1
,
T cell differentiation
,
Inflammatory disorder
,
Lymphocyte
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
proteinase inhibitor
Summary
General Info
Curated Studies
Most Correlated Studies
Drug target sets for approved compounds
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Cathepsin D inhibitors based on tasiamide B derivatives with cell membrane permeability.
Phenylacetyl pepstatin inhibitors of aspartyl proteases from Streptomyces varsoviensis.
A low-background, fluorescent assay to evaluate inhibitors of diverse viral proteases.
Plant Kunitz Inhibitors and Their Interaction with Proteases: Current and Potential Pharmacological …
Cocaprins, β-Trefoil Fold Inhibitors of Cysteine and Aspartic Proteases from Coprinopsis cinerea.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study to Evaluate the Safety and Efficacy of Liquid Alpha1-Proteinase Inhibitor (Human) in Hospitali…
Extension Study of Zemaira® i.v. Administration in Subjects With Emphysema Due to alpha1-proteinase …
Zemaira in Subjects With Emphysema Due to Alpha1-Proteinase Inhibitor Deficiency
Efficacy and Safety Study of Augmentation Therapy With ARALAST Fraction IV-1 (Human Alpha 1 - Protei…
Aralast alpha1-proteinase Inhibitor Surveillance Study
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ